Author

Gjumrakch Aliev

GALLY International Biomedical Research - Cited by 30,607 - Cardiovascular Diseases - Ischemia/Reperfusion - Alzheimer Disease - Mitochondria - Oxidative stress

Biography

Gjumrakch Aliev is a founder and chair of GALLY International Biomedical Research & Consulting LLC, and leading expert on vascular and mitochondrial factors in pathogenesis of various diseases. He is internationally recognized as a leading figure in areas of gerontology, such as atherosclerosis, ischemia/reperfusion, stroke and Alzheimer Disease. He is also the chairman of the International Division of EuroEspes Biomedical Research Center in La Coruna, Spain. Dr. Aliev’s active role in other first rate organizations worldwide allow for unique and outstanding partnerships of great magnitude capable of success in a vast arry of subject areas
Title
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...autophagy 17 (1), 1-382, 202112141202
2021
Mitochondrial mutations and mitoepigenetics: Focus on regulation of oxidative stress-induced responses in breast cancers
K Chen, P Lu, NM Beeraka, OA Sukocheva, SRV Madhunapantula, J Liu, ...Seminars in Cancer Biology 83, 556-569, 2022202
127
2022
Extracellular vesicles in cancer nanomedicine
VV Tarasov, AA Svistunov, VN Chubarev, SA Dostdar, AV Sokolov, ...Seminars in cancer biology , 212-225, 2021202
69
2021
Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress
ME Neganova, SG Klochkov, YR Aleksandrova, G AlievSeminars in Cancer Biology 83, 452-471, 2022202
62
2022
Implications of nanotechnology for the treatment of cancer: Recent advances
SG Klochkov, ME Neganova, VN Nikolenko, K Chen, SG Somasundaram, ...Seminars in cancer biology 69, 190-199, 2021202
49
2021
The role of tumor associated macrophages (TAMs) in cancer progression, chemoresistance, angiogenesis and metastasis-current status
S Dallavalasa, NM Beeraka, CG Basavaraju, SRV Tulimilli, SP Sadhu, ...Current Medicinal Chemistry 28 (), 8203-8236, 2021202
39
2021
COVID-19-related intracerebral hemorrhage
V Pavlov, O Beylerli, I Gareev, LF Torres Solis, A Solís Herrera, G AlievFrontiers in Aging Neuroscience 12, 600172, 2020202
38
2020
Circular RNAs as biomarkers and therapeutic targets in cancer
A Beilerli, I Gareev, O Beylerli, G Yang, V Pavlov, G Aliev, A AhmadSeminars in cancer biology 83, 242-252, 2022202
37
2022
A review on SARS-CoV-2-induced neuroinflammation, neurodevelopmental complications, and recent updates on the vaccine development
M Karnik, NM Beeraka, CA Uthaiah, SM Nataraj, ADS Bettadapura, ...Molecular Neurobiology 58 (9), 4535-4563, 2021202
37
2021
The links between Parkinson’s disease and cancer
M Ejma, N Madetko, A Brzecka, K Guranski, P Alster, M Misiuk-Hojło, ...Biomedicines 8 (10), 416, 2020202
36
2020
Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment
M Koszewicz, J Jaroch, A Brzecka, M Ejma, S Budrewicz, LM Mikhaleva, ...Pharmacological Research 164, 105277, 2021202
35
2021
The crucial role of epigenetic regulation in breast cancer anti-estrogen resistance: Current findings and future perspectives
OA Sukocheva, E Lukina, M Friedemann, M Menschikowski, A Hagelgans, ...Seminars in cancer biology 82, 35-59, 2022202
26
2022
The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity
VP Viswanadha, V Dhivya, NM Beeraka, CY Huang, LV Gavryushova, ...European Journal of Pharmacology 885, 173524,
20
2020
Мetabolic abnormalities of erythrocytes as a risk factor for Alzheimer’s disease.
EA Kosenko, LA Tikhonova, C Montoliu, GE Barreto, G Aliev, ...Front. Neurosci., 11:728., 209920209
20
2099
The current status and challenges in the development of vaccines and drugs against severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2)
NM Beeraka, SRV Tulimilli, M Karnik, SP Sadhu, RR Pragada, G Aliev, ...BioMed Research International 2021, 1-20, 2021202
19
2021
Current understanding of central nervous system drainage systems: implications in the context of neurodegenerative diseases
VN Nikolenko, MV Oganesyan, AD Vovkogon, AT Nikitina, EA Sozonova, ...Current Neuropharmacology (11), 1054-1063, 2020202
18
2020
The mystery of claustral neural circuits and recent updates on its role in neurodegenerative pathology
VN Nikolenko, NA Rizaeva, NM Beeraka, MV Oganesyan, ...Behavioral and brain functions 17 (1), 1-10, 2021202
14
2021
Ocular paraneoplastic syndromes
J Przeździecka-Dołyk, A Brzecka, M Ejma, M Misiuk-Hojło, LF Torres Solis, ...Biomedicines 8 (11), 490, 2020202
14
2020
The dawn of mitophagy: what do we know by now?
DM Belousov, EV Mikhaylenko, SG Somasundaram, CE Kirkland, G AlievCurrent Neuropharmacology 19 (2), 170-192, 2021202
13
2021
Sleep disturbances and cognitive impairment in the course of type 2 diabetes-a possible link
A Brzecka, N Madetko, VN Nikolenko, GM Ashraf, M Ejma, J Leszek, ...Current Neuropharmacology 19 (1), 78-91, 2021202
12
2021